Loratadine
NDC 16571-822, loratadine, tablet, from Rising Pharmaceuticals, Inc.
- Product NDC
- 16571-822
- Status
- Listed
- Labeler
- Rising Pharmaceuticals, Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA214684
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-822-01 | 16571082201 | 100 TABLET in 1 BOTTLE (16571-822-01) |
| 16571-822-03 | 16571082203 | 30 TABLET in 1 BOTTLE (16571-822-03) |
| 16571-822-30 | 16571082230 | 300 TABLET in 1 BOTTLE (16571-822-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 16571082201
GET /v1/drugs/nadac/16571082201NADAC price for package 16571082203
GET /v1/drugs/nadac/16571082203NADAC price for package 16571082230
GET /v1/drugs/nadac/16571082230
Use it
Look up 16571-822 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.